Gene Activity List

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Gene Compound Experiment Study Pathway Assay Report Bug Request Feature
Gene Activity List
You are on Page 1692 of 1714:
1682 1683 1684 1685 1686 1687 1688 1689 1690 1691 1692 1693 1694 1695 1696 1697 1698 1699 1700 1701 1702
Gene Compound Assay Inh Ic50 Ki View
cholinergic receptor, muscarinic 4 CELECOXIB Muscarinic M4 -17% NoneNone NoneNone View
chemokine (C-C motif) receptor 2 ETHANOL Chemokine CCR2B -17% NoneNone NoneNone View
5-hydroxytryptamine (serotonin) receptor 3a TIRILAZAD Serotonin 5-HT3 -17% NoneNone NoneNone View
5-hydroxytryptamine (serotonin) receptor 3b TIRILAZAD Serotonin 5-HT3 -17% NoneNone NoneNone View
prostaglandin-endoperoxide synthase 1 TIRILAZAD Cyclooxygenase COX-1 -17% NoneNone NoneNone View
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) TIRILAZAD Cyclooxygenase COX-1 -17% NoneNone NoneNone View
ATP-binding cassette, sub-family C (CFTR/MRP), member 8 CYCLOSPORIN A Potassium Channel [KATP] -17% NoneNone NoneNone View
ATP-binding cassette, sub-family C (CFTR/MRP), member 9 CYCLOSPORIN A Potassium Channel [KATP] -17% NoneNone NoneNone View
ATP-binding cassette, sub-family C (CFTR/MRP), member 8 CYCLOSPORIN A Potassium Channel [KATP] -17% NoneNone NoneNone View
cholinergic receptor, muscarinic 1 CERIVASTATIN Muscarinic M1 -17% NoneNone NoneNone View
leukotriene B4 receptor 2 CYCLOSPORIN A Leukotriene B4 -17% NoneNone NoneNone View
leukotriene B4 receptor CYCLOSPORIN A Leukotriene B4 -17% NoneNone NoneNone View
leukotriene B4 receptor CYCLOSPORIN A Leukotriene B4 -17% NoneNone NoneNone View
leukotriene B4 receptor 2 CYCLOSPORIN A Leukotriene B4 -17% NoneNone NoneNone View
bradykinin receptor, beta 2 BW-723C86 Bradykinin B2 -17% NoneNone NoneNone View
bradykinin receptor B2 BW-723C86 Bradykinin B2 -17% NoneNone NoneNone View
prostaglandin-endoperoxide synthase 2 BENZO[E]PYRENE Cyclooxygenase COX-2 -17% NoneNone NoneNone View
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) BENZO[E]PYRENE Cyclooxygenase COX-2 -17% NoneNone NoneNone View
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 4 3-METHYLCHOLANTHRENE GABAA, Benzodiazepine, Central -17% NoneNone NoneNone View
gamma-aminobutyric acid A receptor, gamma 1 3-METHYLCHOLANTHRENE GABAA, Benzodiazepine, Central -17% NoneNone NoneNone View
gamma-aminobutyric acid A receptor, pi 3-METHYLCHOLANTHRENE GABAA, Benzodiazepine, Central -17% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha 1F subunit DEXCHLORPHENIRAMINE Calcium Channel Type L, Dihydropyridine -17% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1D subunit DEXCHLORPHENIRAMINE Calcium Channel Type L, Dihydropyridine -17% NoneNone NoneNone View
glutamate receptor, ionotropic, N-methyl-D-aspartate 3B DIDANOSINE Glutamate, NMDA, Agonism -17% NoneNone NoneNone View
prostaglandin-endoperoxide synthase 1 DIDANOSINE Cyclooxygenase COX-1 -17% NoneNone NoneNone View
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) DIDANOSINE Cyclooxygenase COX-1 -17% NoneNone NoneNone View
prostaglandin-endoperoxide synthase 2 SULOCTIDIL Cyclooxygenase COX-2 -17% NoneNone NoneNone View
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) SULOCTIDIL Cyclooxygenase COX-2 -17% NoneNone NoneNone View
prostaglandin-endoperoxide synthase 2 4-(2-THIENYL)BUTYRIC ACID Cyclooxygenase COX-2 -17% NoneNone NoneNone View
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) 4-(2-THIENYL)BUTYRIC ACID Cyclooxygenase COX-2 -17% NoneNone NoneNone View
cytochrome P450, family 3, subfamily a, polypeptide 13 PARAQUAT DICHLORIDE CYP450-3A4 Inhibition -17% NoneNone NoneNone View
adrenergic receptor, alpha 1b AZARIBINE Adrenergic alpha1B -17% NoneNone NoneNone View
ATPase, Na+/K+ transporting, alpha 4 polypeptide BETA-NAPHTHOFLAVONE ATPase, Na+/K+ -17% NoneNone NoneNone View
ATPase, Na+/K+ transporting, alpha 3 polypeptide BETA-NAPHTHOFLAVONE ATPase, Na+/K+ -17% NoneNone NoneNone View
ATPase, Na+/K+ transporting, alpha 2 polypeptide BETA-NAPHTHOFLAVONE ATPase, Na+/K+ -17% NoneNone NoneNone View
ATPase, Na+/K+ transporting, alpha 1 polypeptide BETA-NAPHTHOFLAVONE ATPase, Na+/K+ -17% NoneNone NoneNone View
ATPase, Na+/K+ transporting, beta 1 polypeptide BETA-NAPHTHOFLAVONE ATPase, Na+/K+ -17% NoneNone NoneNone View
ATPase, Na+/K+ transporting, beta 3 polypeptide BETA-NAPHTHOFLAVONE ATPase, Na+/K+ -17% NoneNone NoneNone View
ATPase, Na+/K+ transporting, beta 2 polypeptide BETA-NAPHTHOFLAVONE ATPase, Na+/K+ -17% NoneNone NoneNone View
ATPase, (Na+)/K+ transporting, beta 4 polypeptide BETA-NAPHTHOFLAVONE ATPase, Na+/K+ -17% NoneNone NoneNone View
sodium channel, voltage-gated, type IX, alpha ALFACALCIDOL Sodium Channel, Site 2 -17% NoneNone NoneNone View
sodium channel, voltage gated, type VIII, alpha ALFACALCIDOL Sodium Channel, Site 2 -17% NoneNone NoneNone View
sodium channel, voltage-gated, type VII, alpha ALFACALCIDOL Sodium Channel, Site 2 -17% NoneNone NoneNone View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) ALFACALCIDOL Sodium Channel, Site 2 -17% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, beta ALFACALCIDOL Sodium Channel, Site 2 -17% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, alpha ALFACALCIDOL Sodium Channel, Site 2 -17% NoneNone NoneNone View
sodium channel, voltage-gated, type III, alpha ALFACALCIDOL Sodium Channel, Site 2 -17% NoneNone NoneNone View
sodium channel, voltage-gated, type II, beta ALFACALCIDOL Sodium Channel, Site 2 -17% NoneNone NoneNone View
glutamate receptor, ionotropic, NMDA2C GERANIOL Glutamate, NMDA, Phencyclidine -18% NoneNone NoneNone View
glutamate receptor, ionotropic, N-methyl D-aspartate 2B GERANIOL Glutamate, NMDA, Phencyclidine -18% NoneNone NoneNone View
glutamate receptor, ionotropic, N-methyl D-aspartate 2A GERANIOL Glutamate, NMDA, Phencyclidine -18% NoneNone NoneNone View
N-methyl-D-aspartate receptor 1 (Grin1) gene, exons 1 through 6 and partial cds; alternatively spliced (Rn.) GERANIOL Glutamate, NMDA, Phencyclidine -18% NoneNone NoneNone View
glutamate receptor, ionotropic, N-methyl-D-aspartate 3B GERANIOL Glutamate, NMDA, Phencyclidine -18% NoneNone NoneNone View
adrenergic receptor, beta 3 GLIMEPIRIDE Adrenergic beta3 -18% NoneNone NoneNone View
thromboxane A synthase 1 SULFAMETHIZOLE Thromboxane Synthetase -18% NoneNone NoneNone View
thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) SULFAMETHIZOLE Thromboxane Synthetase -18% NoneNone NoneNone View
histamine receptor H 2 DANOFLOXACIN Histamine H2 -18% NoneNone NoneNone View
adrenergic receptor, alpha 2b CHOLINE CHLORIDE Adrenergic alpha2C -18% NoneNone NoneNone View
adrenergic receptor, alpha 2c (Non-specific probe) CHOLINE CHLORIDE Adrenergic alpha2C -18% NoneNone NoneNone View
5-hydroxytryptamine (serotonin) receptor 3a CLOPIDOGREL Serotonin 5-HT3 -18% NoneNone NoneNone View
5-hydroxytryptamine (serotonin) receptor 3b CLOPIDOGREL Serotonin 5-HT3 -18% NoneNone NoneNone View
cholinergic receptor, muscarinic 1 CHOLECALCIFEROL Muscarinic M1 -18% NoneNone NoneNone View
3-hydroxy-3-methylglutaryl-Coenzyme A reductase DIPHENHYDRAMINE HMG-CoA Reductase -18% NoneNone NoneNone View
3-hydroxy-3-methylglutaryl-Coenzyme A reductase DIPHENHYDRAMINE HMG-CoA Reductase -18% NoneNone NoneNone View
natriuretic peptide receptor 2 TRIHEXYPHENIDYL Atrial Natriuretic Factor (ANF) -18% NoneNone NoneNone View
guanylate cyclase A/atrial natriuretic peptide receptor (Non-specific probe) TRIHEXYPHENIDYL Atrial Natriuretic Factor (ANF) -18% NoneNone NoneNone View
natriuretic peptide receptor 3 TRIHEXYPHENIDYL Atrial Natriuretic Factor (ANF) -18% NoneNone NoneNone View
DNA encoding receptor of vasoactive intestinal polypeptide DIPHENHYDRAMINE Vasoactive Intestinal Peptide VIP1 -18% NoneNone NoneNone View
leukotriene C4 synthase 1-(2-METHYLBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE Leukotriene C4 Synthetase -18% NoneNone NoneNone View
leukotriene C4 synthase 1-(2-METHYLBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE Leukotriene C4 Synthetase -18% NoneNone NoneNone View
ATP-binding cassette, sub-family C (CFTR/MRP), member 8 BUPIVACAINE HYDROCHLORIDE Potassium Channel [KATP] -18% NoneNone NoneNone View
glycine receptor, beta subunit PRAVASTATIN Glycine, Strychnine-Sensitive -18% NoneNone NoneNone View
glycine receptor, alpha 2 subunit PRAVASTATIN Glycine, Strychnine-Sensitive -18% NoneNone NoneNone View
glycine receptor, alpha 3 PRAVASTATIN Glycine, Strychnine-Sensitive -18% NoneNone NoneNone View
glycine receptor, alpha 1 subunit PRAVASTATIN Glycine, Strychnine-Sensitive -18% NoneNone NoneNone View
cannabinoid receptor 1 (brain) SALBUTAMOL Cannabinoid CB1 -18% NoneNone NoneNone View
adenosine A2a receptor TOSUFLOXACIN Adenosine A2A -18% NoneNone NoneNone View
chemokine (C-C motif) receptor 5 TOSUFLOXACIN Chemokine CCR5 -18% NoneNone NoneNone View
interleukin 8 receptor, alpha PROCAINAMIDE Chemokine CXCR1(IL-8A) -18% NoneNone NoneNone View
glutamate receptor, ionotropic, N-methyl D-aspartate 2D RWJ-68354 Glutamate, NMDA, Phencyclidine -17% NoneNone NoneNone View
glutamate receptor, ionotropic, NMDA2C RWJ-68354 Glutamate, NMDA, Phencyclidine -17% NoneNone NoneNone View
glutamate receptor, ionotropic, N-methyl D-aspartate 2B RWJ-68354 Glutamate, NMDA, Phencyclidine -17% NoneNone NoneNone View
glutamate receptor, ionotropic, N-methyl D-aspartate 2A RWJ-68354 Glutamate, NMDA, Phencyclidine -17% NoneNone NoneNone View
N-methyl-D-aspartate receptor 1 (Grin1) gene, exons 1 through 6 and partial cds; alternatively spliced (Rn.) RWJ-68354 Glutamate, NMDA, Phencyclidine -17% NoneNone NoneNone View
glutamate receptor, ionotropic, N-methyl-D-aspartate 3B RWJ-68354 Glutamate, NMDA, Phencyclidine -17% NoneNone NoneNone View
ATPase, Na+/K+ transporting, alpha 4 polypeptide LEAD (II) ACETATE ATPase, Na+/K+ -17% NoneNone NoneNone View
ATPase, Na+/K+ transporting, alpha 3 polypeptide LEAD (II) ACETATE ATPase, Na+/K+ -17% NoneNone NoneNone View
ATPase, Na+/K+ transporting, alpha 2 polypeptide LEAD (II) ACETATE ATPase, Na+/K+ -17% NoneNone NoneNone View
ATPase, Na+/K+ transporting, alpha 1 polypeptide LEAD (II) ACETATE ATPase, Na+/K+ -17% NoneNone NoneNone View
ATPase, Na+/K+ transporting, beta 1 polypeptide LEAD (II) ACETATE ATPase, Na+/K+ -17% NoneNone NoneNone View
ATPase, Na+/K+ transporting, beta 3 polypeptide LEAD (II) ACETATE ATPase, Na+/K+ -17% NoneNone NoneNone View
ATPase, Na+/K+ transporting, beta 2 polypeptide LEAD (II) ACETATE ATPase, Na+/K+ -17% NoneNone NoneNone View
ATPase, (Na+)/K+ transporting, beta 4 polypeptide LEAD (II) ACETATE ATPase, Na+/K+ -17% NoneNone NoneNone View
A3 adenosine receptor VINCRISTINE Adenosine A3 -17% NoneNone NoneNone View
sodium channel, voltage-gated, type I, beta CARBAMAZEPINE Sodium Channel, Site 2 -17% NoneNone NoneNone View
sodium channel, voltage-gated, type 10, alpha polypeptide CARBAMAZEPINE Sodium Channel, Site 2 -17% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, alpha polypeptide CARBAMAZEPINE Sodium Channel, Site 2 -17% NoneNone NoneNone View
sodium channel, voltage-gated, type V, alpha polypeptide CARBAMAZEPINE Sodium Channel, Site 2 -17% NoneNone NoneNone View
sodium channel, voltage-gated, type II, beta CARBAMAZEPINE Sodium Channel, Site 2 -17% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 alpha CARBAMAZEPINE Sodium Channel, Site 2 -17% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 gamma CARBAMAZEPINE Sodium Channel, Site 2 -17% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 beta CARBAMAZEPINE Sodium Channel, Site 2 -17% NoneNone NoneNone View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide CARBAMAZEPINE Sodium Channel, Site 2 -17% NoneNone NoneNone View
sodium channel, voltage-gated, type XI, alpha CARBAMAZEPINE Sodium Channel, Site 2 -17% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1, gamma CARBAMAZEPINE Sodium Channel, Site 2 -17% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1, delta CARBAMAZEPINE Sodium Channel, Site 2 -17% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) CARBAMAZEPINE Sodium Channel, Site 2 -17% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 alpha CARBAMAZEPINE Sodium Channel, Site 2 -17% NoneNone NoneNone View
sodium channel, voltage-gated, type X, alpha CARBAMAZEPINE Sodium Channel, Site 2 -17% NoneNone NoneNone View
sodium channel, voltage-gated, type IX, alpha CARBAMAZEPINE Sodium Channel, Site 2 -17% NoneNone NoneNone View
sodium channel, voltage gated, type VIII, alpha CARBAMAZEPINE Sodium Channel, Site 2 -17% NoneNone NoneNone View
sodium channel, voltage-gated, type VII, alpha CARBAMAZEPINE Sodium Channel, Site 2 -17% NoneNone NoneNone View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) CARBAMAZEPINE Sodium Channel, Site 2 -17% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, beta CARBAMAZEPINE Sodium Channel, Site 2 -17% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, alpha CARBAMAZEPINE Sodium Channel, Site 2 -17% NoneNone NoneNone View
sodium channel, voltage-gated, type III, alpha CARBAMAZEPINE Sodium Channel, Site 2 -17% NoneNone NoneNone View
sodium channel, voltage-gated, type II, beta CARBAMAZEPINE Sodium Channel, Site 2 -17% NoneNone NoneNone View
sodium channel, voltage-gated, type II, alpha 2 CARBAMAZEPINE Sodium Channel, Site 2 -17% NoneNone NoneNone View
sodium channel, voltage-gated, type I, beta CARBAMAZEPINE Sodium Channel, Site 2 -17% NoneNone NoneNone View
sodium channel, voltage-gated, type I, alpha CARBAMAZEPINE Sodium Channel, Site 2 -17% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, beta CARBAMAZEPINE Sodium Channel, Site 2 -17% NoneNone NoneNone View
sodium channel associated protein 1 CARBAMAZEPINE Sodium Channel, Site 2 -17% NoneNone NoneNone View
sodium channel associated protein 2 CARBAMAZEPINE Sodium Channel, Site 2 -17% NoneNone NoneNone View
sodium channel, voltage-gated, type III, beta CARBAMAZEPINE Sodium Channel, Site 2 -17% NoneNone NoneNone View
sodium channel, voltage-gated, type I, alpha CARBAMAZEPINE Sodium Channel, Site 2 -17% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 4 VALPROIC ACID Calcium Channel Type L, Benzothiazepine -17% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 3 VALPROIC ACID Calcium Channel Type L, Benzothiazepine -17% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 2 VALPROIC ACID Calcium Channel Type L, Benzothiazepine -17% NoneNone NoneNone View
calcium channel, voltage-dependent, gamma subunit 1 VALPROIC ACID Calcium Channel Type L, Benzothiazepine -17% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 4 subunit VALPROIC ACID Calcium Channel Type L, Benzothiazepine -17% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 3 subunit VALPROIC ACID Calcium Channel Type L, Benzothiazepine -17% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 2 subunit VALPROIC ACID Calcium Channel Type L, Benzothiazepine -17% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1S subunit VALPROIC ACID Calcium Channel Type L, Benzothiazepine -17% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1C subunit DEXCHLORPHENIRAMINE Calcium Channel Type L, Dihydropyridine -17% NoneNone NoneNone View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit DEXCHLORPHENIRAMINE Calcium Channel Type L, Dihydropyridine -17% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 1 subunit DEXCHLORPHENIRAMINE Calcium Channel Type L, Dihydropyridine -17% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1E subunit DEXCHLORPHENIRAMINE Calcium Channel Type L, Dihydropyridine -17% NoneNone NoneNone View
calcium channel, voltage-dependent, N type, alpha 1B subunit DEXCHLORPHENIRAMINE Calcium Channel Type L, Dihydropyridine -17% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha2/delta subunit 1 DEXCHLORPHENIRAMINE Calcium Channel Type L, Dihydropyridine -17% NoneNone NoneNone View
Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) BENZO[A]PYRENE CYP450-2C9 Inhibition -17% NoneNone NoneNone View
cytochrome P450, family 2, subfamily C, polypeptide 9 BENZO[A]PYRENE CYP450-2C9 Inhibition -17% NoneNone NoneNone View
lymphocyte protein tyrosine kinase (mapped) S-(N-BENZYLTHIOCARBAMOYL)-L-CYSTEINE Protein Tyrosine Kinase, Lck -17% NoneNone NoneNone View
A3 adenosine receptor ANISOMYCIN Adenosine A3 -17% NoneNone NoneNone View
lymphocyte protein tyrosine kinase (mapped) DEXCHLORPHENIRAMINE Protein Tyrosine Kinase, Lck -17% NoneNone NoneNone View
cholinergic receptor, muscarinic 1 ALPHA-TOCOPHEROL Muscarinic M1 -17% NoneNone NoneNone View
ATP-binding cassette, sub-family C (CFTR/MRP), member 8 ALBENDAZOLE Potassium Channel [KATP] -17% NoneNone NoneNone View
ATP-binding cassette, sub-family C (CFTR/MRP), member 9 ALBENDAZOLE Potassium Channel [KATP] -17% NoneNone NoneNone View
ATP-binding cassette, sub-family C (CFTR/MRP), member 8 ALBENDAZOLE Potassium Channel [KATP] -17% NoneNone NoneNone View
epidermal growth factor receptor ACETAZOLAMIDE Protein Tyrosine Kinase, EGF Receptor -17% NoneNone NoneNone View
cholinergic receptor, muscarinic 1 TOBRAMYCIN Muscarinic M1 -17% NoneNone NoneNone View
ATPase, Na+/K+ transporting, alpha 3 polypeptide PREDNISOLONE ATPase, Na+/K+ -17% NoneNone NoneNone View
ATPase, Na+/K+ transporting, alpha 2 polypeptide PREDNISOLONE ATPase, Na+/K+ -17% NoneNone NoneNone View
ATPase, Na+/K+ transporting, alpha 1 polypeptide PREDNISOLONE ATPase, Na+/K+ -17% NoneNone NoneNone View
ATPase, Na+/K+ transporting, beta 1 polypeptide PREDNISOLONE ATPase, Na+/K+ -17% NoneNone NoneNone View
ATPase, Na+/K+ transporting, beta 3 polypeptide PREDNISOLONE ATPase, Na+/K+ -17% NoneNone NoneNone View
ATPase, Na+/K+ transporting, beta 2 polypeptide PREDNISOLONE ATPase, Na+/K+ -17% NoneNone NoneNone View
ATPase, (Na+)/K+ transporting, beta 4 polypeptide PREDNISOLONE ATPase, Na+/K+ -17% NoneNone NoneNone View
purinergic receptor P2X, ligand-gated ion channel, 1 MEVASTATIN Purinergic P2X -17% NoneNone NoneNone View
purinergic receptor P2X, ligand-gated ion channel, 7 MEVASTATIN Purinergic P2X -17% NoneNone NoneNone View
purinergic receptor P2X-like 1, orphan receptor MEVASTATIN Purinergic P2X -17% NoneNone NoneNone View
5-hydroxytryptamine (serotonin) receptor 2A TYRPHOSTIN A23 Serotonin 5-HT2A -17% NoneNone NoneNone View
ATPase, Na+/K+ transporting, alpha 4 polypeptide PREDNISOLONE ATPase, Na+/K+ -17% NoneNone NoneNone View
platelet-derived growth factor receptor, beta polypeptide CYCLOHEXIMIDE Platelet-Derived Growth Factor (PDGF) -17% NoneNone NoneNone View
opioid receptor, delta 1 CYCLOHEXIMIDE Opiate delta -17% NoneNone NoneNone View
platelet derived growth factor receptor, alpha polypeptide CYCLOHEXIMIDE Platelet-Derived Growth Factor (PDGF) -17% NoneNone NoneNone View
platelet-derived growth factor receptor, alpha polypeptide CYCLOHEXIMIDE Platelet-Derived Growth Factor (PDGF) -17% NoneNone NoneNone View
platelet derived growth factor receptor, beta polypeptide CYCLOHEXIMIDE Platelet-Derived Growth Factor (PDGF) -17% NoneNone NoneNone View
leukotriene B4 receptor 2 AURANOFIN Leukotriene B4 -17% NoneNone NoneNone View
leukotriene B4 receptor AURANOFIN Leukotriene B4 -17% NoneNone NoneNone View
leukotriene B4 receptor AURANOFIN Leukotriene B4 -17% NoneNone NoneNone View
leukotriene B4 receptor 2 AURANOFIN Leukotriene B4 -17% NoneNone NoneNone View
neuropeptide Y receptor Y1 CEFOTAXIME Neuropeptide Y1 -17% NoneNone NoneNone View
mitogen activated protein kinase 14 CEFOTAXIME Protein Serine/Threonine Kinase, p38alpha -17% NoneNone NoneNone View
mitogen-activated protein kinase 14 CEFOTAXIME Protein Serine/Threonine Kinase, p38alpha -17% NoneNone NoneNone View
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) CAMPTOTHECIN Protein Tyrosine Kinase, HER2 Receptor -17% NoneNone NoneNone View
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) CAMPTOTHECIN Protein Tyrosine Kinase, HER2 Receptor -17% NoneNone NoneNone View
platelet-activating factor receptor CAMPTOTHECIN Platelet Activating Factor (PAF) -17% NoneNone NoneNone View
mitogen activated protein kinase 1 DIETHYLSTILBESTROL Protein Serine/Threonine Kinase, ERK2 -17% NoneNone NoneNone View
mitogen-activated protein kinase 1 DIETHYLSTILBESTROL Protein Serine/Threonine Kinase, ERK2 -17% NoneNone NoneNone View
Cytochrom P450-1A2 monooxygenase 3-AMINOBENZAMIDE CYP450-1A2 Inhibition -17% NoneNone NoneNone View
Cytochrom P450-1A2 monooxygenase AMINOCAPROIC ACID CYP450-1A2 Inhibition -17% NoneNone NoneNone View
purinergic receptor P2X, ligand-gated ion channel, 1 MIFEPRISTONE Purinergic P2X -17% NoneNone NoneNone View
purinergic receptor P2X, ligand-gated ion channel, 7 MIFEPRISTONE Purinergic P2X -17% NoneNone NoneNone View
purinergic receptor P2X-like 1, orphan receptor MIFEPRISTONE Purinergic P2X -17% NoneNone NoneNone View
Cytochrom P450-1A2 monooxygenase BISACODYL CYP450-1A2 Inhibition -17% NoneNone NoneNone View
natriuretic peptide receptor 2 ENALAPRIL Atrial Natriuretic Factor (ANF) -17% NoneNone NoneNone View
guanylate cyclase A/atrial natriuretic peptide receptor (Non-specific probe) ENALAPRIL Atrial Natriuretic Factor (ANF) -17% NoneNone NoneNone View
natriuretic peptide receptor 3 ENALAPRIL Atrial Natriuretic Factor (ANF) -17% NoneNone NoneNone View
cholinergic receptor, muscarinic 4 ZAFIRLUKAST Muscarinic M4 -17% NoneNone NoneNone View
leukotriene C4 synthase ZAFIRLUKAST Leukotriene C4 Synthetase -17% NoneNone NoneNone View
leukotriene C4 synthase ZAFIRLUKAST Leukotriene C4 Synthetase -17% NoneNone NoneNone View
adrenergic receptor, alpha 2a CITRIC ACID Imidazoline I2, Central -17% NoneNone NoneNone View
adrenergic receptor, alpha 2c (Non-specific probe) CITRIC ACID Imidazoline I2, Central -17% NoneNone NoneNone View
3-hydroxy-3-methylglutaryl-Coenzyme A reductase 1,3-DIPHENYLGUANIDINE HMG-CoA Reductase -17% NoneNone NoneNone View
3-hydroxy-3-methylglutaryl-Coenzyme A reductase 1,3-DIPHENYLGUANIDINE HMG-CoA Reductase -17% NoneNone NoneNone View
glutamate receptor, ionotropic, AMPA1 (alpha 1) IMATINIB Glutamate, AMPA -17% NoneNone NoneNone View
glutamate receptor, ionotropic, AMPA2 IMATINIB Glutamate, AMPA -17% NoneNone NoneNone View
glutamate receptor, ionotropic, AMPA3 (alpha 3) IMATINIB Glutamate, AMPA -17% NoneNone NoneNone View
potassium voltage-gated channel, subfamily H, member 8 TROXIPIDE Potassium Channel HERG -17% NoneNone NoneNone View
potassium voltage-gated channel, subfamily H (eag-related), member 6 TROXIPIDE Potassium Channel HERG -17% NoneNone NoneNone View